Track: Neurological Disorders

The "Neurological Disorders" track offers an in-depth exploration of prevalent and emerging conditions affecting the brain, spinal cord, and nervous system. This session provides insights into the pathophysiology, diagnosis, and management of neurological disorders while emphasizing recent advancements in therapeutic strategies, neuroimaging, and personalized care. Participants will engage with leading experts to discuss innovative research and clinical approaches that are improving patient outcomes across a spectrum of neurological conditions.
Alzheimer’s Disease:
The latest research on Alzheimer’s disease, focusing on early detection through biomarkers, genetic predispositions, and advancements in neuroimaging. Participants will also explore novel therapeutic approaches, including monoclonal antibodies targeting amyloid and tau proteins, as well as strategies for enhancing cognitive function and quality of life in affected individuals.
Parkinson’s Disease:
Discussions will focus on breakthroughs in understanding the neurodegenerative processes underlying Parkinson’s disease. Topics include advances in deep brain stimulation (DBS), new pharmacological therapies, and the potential of gene therapy and stem cell research to alter disease progression. Attendees will also learn about innovative approaches to managing motor and non-motor symptoms.
Stroke:
The Stroke session highlights the latest developments in stroke prevention, acute management, and rehabilitation. Key topics include advancements in thrombectomy techniques, neuroprotective agents, and post-stroke neuroplasticity. Discussions will also address risk factor modification and the role of telemedicine in improving stroke care access and outcomes.
Epilepsy and Seizures:
This session explores the latest diagnostic tools, including EEG advancements and imaging techniques, to identify epilepsy syndromes accurately. Participants will learn about novel treatments such as neuromodulation, ketogenic diets, and cutting-edge antiepileptic drugs. Emerging therapies for refractory epilepsy and seizure prediction technologies will also be discussed.
Dementia:
Beyond Alzheimer’s, this segment focuses on other forms of dementia, including vascular dementia, Lewy body dementia, and frontotemporal dementia. Discussions will cover differential diagnosis, the role of neuroinflammation, and emerging pharmacological and non-pharmacological interventions aimed at slowing disease progression and enhancing patient and caregiver quality of life.
Headaches:
This track addresses the management of primary and secondary headache disorders, including migraines, cluster headaches, and tension-type headaches. Attendees will explore advancements in headache diagnostics, the role of CGRP inhibitors, and lifestyle interventions, along with alternative therapies like acupuncture and mindfulness for headache relief.
Acute Spinal Cord Injury:
This session focuses on the latest strategies for managing and rehabilitating acute spinal cord injuries. Discussions will include advances in surgical techniques, neuroprotective agents, and the role of neurorehabilitation and assistive technologies in promoting functional recovery and improving quality of life for patients.
Autism Spectrum Disorder:
This session explores the neurobiological underpinnings of autism spectrum disorder (ASD) and emerging therapies to address core symptoms and comorbidities. Topics include early intervention strategies, advancements in behavioral therapies, and the role of digital tools and assistive technologies in enhancing social and communication skills.
Down Syndrome:
The Down Syndrome session highlights the neurological aspects of Down syndrome, including its connection to Alzheimer’s disease and other cognitive challenges. Attendees will learn about advances in genetic research, therapies aimed at improving developmental outcomes, and strategies for managing comorbid neurological conditions.
This Session offers a comprehensive exploration of neurological disorders, providing attendees with actionable insights to enhance clinical practice, foster innovation, and improve patient care across a diverse range of conditions.
Scientific Highlights
- Advances in Neuropsychiatry
- Cognitive and Behavioural Neuroscience
- Mental Health and Psychiatry
- Neurological Disorders
- Child and Adolescent Psychiatry
- Neuro-Oncology
- Paediatric Neurology
- Central Nervous System and Neuropathology
- Neuroimaging and Brain Mapping
- Adult Neurogenesis
- Neuro-Ophthalmology & Visual Neuroscience
- Neurosurgery
- Neuropharmacology and Neuroendocrinology
- Neurotechnology and Neurorehabilitation
- Neuro Anatomy